SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950144-05-003581
Filing Date
2005-04-06
Accepted
2005-04-06 10:26:43
Documents
5
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 ATHEROGENICS, INC. g94294a1e10vkza.htm 10-K/A 104241
2 EX-3.01 FOURTH AMENDED AND RESTATED ARTICLES OF INCORPORATION g94294a1exv3w01.txt EX-3.01 15124
3 EX-4.04 GLOBAL 4 1/2% CONVERTIBLE NOTE DUE 2008 g94294a1exv4w04.txt EX-4.04 26727
4 EX-31.3 SECTION 302 CERTIFICATION OF THE CEO g94294a1exv31w3.txt EX-31.3 970
5 EX-31.4 SECTION 302 CERTIFICATION OF THE CFO g94294a1exv31w4.txt EX-31.4 1024
  Complete submission text file 0000950144-05-003581.txt   150124
Mailing Address
Business Address 8995 WESTSIDE PARKWAY ALPHARETTA GA 30004 6783362500
ATHEROGENICS INC (Filer) CIK: 0001107601 (see all company filings)

IRS No.: 582108232 | State of Incorp.: GA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-31261 | Film No.: 05735947
SIC: 2834 Pharmaceutical Preparations